Bullous Drug Eruption with Low Dose Methotrexate
نویسندگان
چکیده
منابع مشابه
Ciprofloxacin-induced generalized bullous fixed drug eruption.
1. Vincent SD, Fotos PG, Baker KA, Williams TP. Oral lichen planus: The clinical, histological and therapeutic features of 100 cases. Oral Surg Oral Med Oral Pathol 1990;70:165-71. 2. Eisen D. The evaluation of cutaneous, genital, scalp, nail, esophageal, and ocular involvement in patients with oral lichen planus. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;91:431-6. 3. Van der Meij E...
متن کاملTitle Generalized Bullous Fixed Drug Eruption
We describe a patient with a generalized bullous form of Fixed Drug Eruption (FDE) induced by bromhexine, a commonly used drug for respiratory symptoms. This is a rare association and generalized bullous FDE is also very rare. We emphasize the importance of patch tests in identifying the culprit drug.
متن کاملLichenoid Drug Eruption after Low-Dose Imatinib Mesylate Treatment
500 Ann Dermatol Received October 19, 2012, Revised December 1, 2012, Accepted for publication December 5, 2012 Corresponding author: Dong-Youn Lee, Department of Dermatology, Samsung Medical Center, 81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea. Tel: 82-2-3410-3543, Fax: 82-2-3410-3869, E-mail: dylee@ skku.edu This is an Open Access article distributed under the terms of the Creative Commons A...
متن کاملBullous drug eruption secondary to nicotinic acid/laropiprant.
Dear Editor, Nicotinamide with tetracycline or doxycycline is used in the treatment of bullous pemphigoid. Nicotinamide is used in doses of 1500 to 2000 mg/day in divided doses in these cases. Nicotinic acid/laropiprant (Tredaptive®) is a lipid lowering agent which contains 1000 mg of nicotinic acid (niacin) and 20 mg of laropiprant which is a selective antagonist of prostaglandin D2 receptor. ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Northern Clinics of Istanbul
سال: 2020
ISSN: 2148-4902
DOI: 10.14744/nci.2020.83798